In-silico-based Lead Optimization of Hit Compounds Targeting Mitotic Kinesin Eg5 for Cancer Management

Overview

Journal In Silico Pharmacol

Date 2025 Jan 9

PMID 39780769

Authors

Damilola S Bodun

Damilola A Omoboyowa

Victor F Olofinlade

Adeyemi O Ayodeji

Andrea Mauri

Uchechukwu C Ogbodo

Toheeb A Balogun

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-024-00300-6.

Citing Articles

Reflecting on Dunbar's numbers: Individual differences in energy allocation to personal relationships.

Li W, Lee D, Stahl J, Bayer J PLoS One. 2025; 20(3):e0319604.

PMID: 40067868 PMC: 11896044. DOI: 10.1371/journal.pone.0319604.

References

Wang J, Mao J, Wang M, Le X, Wang Y . Explore drug-like space with deep generative models. Methods. 2023; 210:52-59. DOI: 10.1016/j.ymeth.2023.01.004. View

Wei W, Cherukupalli S, Jing L, Liu X, Zhan P . Fsp: A new parameter for drug-likeness. Drug Discov Today. 2020; 25(10):1839-1845. DOI: 10.1016/j.drudis.2020.07.017. View

Melit Devassy B, George S . Dimensionality reduction and visualisation of hyperspectral ink data using t-SNE. Forensic Sci Int. 2020; 311:110194. DOI: 10.1016/j.forsciint.2020.110194. View

Wang M, Wang Z, Sun H, Wang J, Shen C, Weng G . Deep learning approaches for de novo drug design: An overview. Curr Opin Struct Biol. 2021; 72:135-144. DOI: 10.1016/j.sbi.2021.10.001. View

Langdon S, Ertl P, Brown N . Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization. Mol Inform. 2016; 29(5):366-85. DOI: 10.1002/minf.201000019. View

Ain Q, Aleksandrova A, Roessler F, Ballester P . Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening. Wiley Interdiscip Rev Comput Mol Sci. 2016; 5(6):405-424. PMC: 4832270. DOI: 10.1002/wcms.1225. View

Elmaaty A, A Hamed M, Ismail M, Elkaeed E, Abulkhair H, Khattab M . Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization. Molecules. 2021; 26(12). PMC: 8234583. DOI: 10.3390/molecules26123772. View

Swallow S . Fluorine in medicinal chemistry. Prog Med Chem. 2015; 54:65-133. DOI: 10.1016/bs.pmch.2014.11.001. View

Shah P, Westwell A . The role of fluorine in medicinal chemistry. J Enzyme Inhib Med Chem. 2007; 22(5):527-40. DOI: 10.1080/14756360701425014. View

10.

Shaker B, Ahmad S, Lee J, Jung C, Na D . In silico methods and tools for drug discovery. Comput Biol Med. 2021; 137:104851. DOI: 10.1016/j.compbiomed.2021.104851. View

11.

Allegra M, Tutone M, Tesoriere L, Attanzio A, Culletta G, Almerico A . Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics. Front Pharmacol. 2021; 12:701568. PMC: 8461089. DOI: 10.3389/fphar.2021.701568. View

12.

Bodun D, Omoboyowa D, Omotuyi O, Olugbogi E, Balogun T, Ezeh C . QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitors. Comput Biol Chem. 2023; 104:107865. DOI: 10.1016/j.compbiolchem.2023.107865. View

13.

Sherman W, Beard H, Farid R . Use of an induced fit receptor structure in virtual screening. Chem Biol Drug Des. 2006; 67(1):83-4. DOI: 10.1111/j.1747-0285.2005.00327.x. View

14.

Bai Q, Tan S, Xu T, Liu H, Huang J, Yao X . MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm. Brief Bioinform. 2020; 22(3). PMC: 7454275. DOI: 10.1093/bib/bbaa161. View

15.

Mignani S, Rodrigues J, Tomas H, Jalal R, Pal Singh P, Majoral J . Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?. Drug Discov Today. 2018; 23(3):605-615. DOI: 10.1016/j.drudis.2018.01.010. View

16.

Miller E, Murphy R, Sindhikara D, Borrelli K, Grisewood M, Ranalli F . Reliable and Accurate Solution to the Induced Fit Docking Problem for Protein-Ligand Binding. J Chem Theory Comput. 2021; 17(4):2630-2639. DOI: 10.1021/acs.jctc.1c00136. View

17.

Boitreaud J, Mallet V, Oliver C, Waldispuhl J . OptiMol: Optimization of Binding Affinities in Chemical Space for Drug Discovery. J Chem Inf Model. 2020; 60(12):5658-5666. DOI: 10.1021/acs.jcim.0c00833. View

18.

Elekofehinti O, Iwaloye O, Molehin O, Famusiwa C . Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation. In Silico Pharmacol. 2021; 9(1):49. PMC: 8349134. DOI: 10.1007/s40203-021-00109-7. View

19.

Anisimova N, Kiselevsky M, Sosnov A, Sadovnikov S, Stankov I, Gakh A . Trans-, cis-, and dihydro-resveratrol: a comparative study. Chem Cent J. 2011; 5:88. PMC: 3313904. DOI: 10.1186/1752-153X-5-88. View

20.

Zhang H, Liang B, Sang X, An J, Huang Z . Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method. Viruses. 2023; 15(4). PMC: 10143255. DOI: 10.3390/v15040891. View